#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephropathy Hypochromic anaemia Diffuse large B-cell lymphoma Neuroendocrine tumour of the lung Liposarcoma metastatic Phenylketonuria Severe myoclonic epilepsy of infancy Toxic epidermal necrolysis Endometrial cancer recurrent Spinal muscular atrophy Juvenile psoriatic arthritis Leiomyosarcoma metastatic Hereditary spastic paraplegia Gastrointestinal neuroendocrine tumour Liver abscess More trials…

    Learn about Rare Diseases

    Lymphangioma – Life with Disease Fabry’s disease – Diagnostics Mast cell activation syndrome – Diagnostics IgA nephropathy – Life with Disease Haemophilia B without inhibitors – Treatment Osteosarcoma – Life with Disease Synovial sarcoma – Trials in Disease Hereditary motor and sensory neuropathy – Life with Disease Gaucher’s disease type I – Basic Information Von Willebrand’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000030810 Tak-280 VALACICLOVIR HYDROCHLORIDE Tusamitamab Ravtansine Contezolid Pp1493 Paracetamol Ph. Eur. IHMA-2121771-1 Vancomycin GSKVX000000070248 Lixudebart Regtivex Methotrexate Pervi-Fus Alpha-Tocopherol RO7268489 Fentanyl Etidronate Disodium Regn7257 TAZAROTENE More therapies…

    Learn about Your Condition

    Connective tissue disorder Conjunctivitis Stress Autoimmune haemolytic anaemia Malignant melanoma of eyelid Corticobasal degeneration Erdheim-Chester disease Diabetes mellitus Liver transplant rejection Metabolic syndrome Low cardiac output syndrome Gender dysphoria Neuroblastoma Hypopituitarism Rectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effect of Acyclovir in ICU Patients with Pneumonia and Herpes Simplex Virus Type 1 Detected in Lung Fluid

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes simplex
    Investigated Drugs:
    • Aciclovir
    Germany

  • Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

    Recruiting

    3 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    Belgium

  • Study on Early Use of Norepinephrine vs. Standard Fluid Therapy in Emergency Department Patients with Hypotension or Shock

    Recruiting

    3 1 1 1
    Denmark Sweden

  • Study on Predicting Blood Pressure Response in Hypertension Patients Using Amlodipine, Olmesartan Medoxomil, Hydrochlorothiazide, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amlodipine
    • Hydrochlorothiazide
    • Olmesartan Medoxomil
    The Netherlands

  • Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Ro7589655
    Italy Poland Spain

  • Study on Duloxetine for Reducing Chronic Pain After Inguinal Hernia Surgery in High-Risk Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pain
    Investigated Drugs:
    • Duloxetine
    Spain
Previous Page
1 … 530 531 532 533 534 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!